# A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

> clinical trial · VERIFIED · 2026-06-23

Status: RECRUITING · Sponsor: Novartis Pharmaceuticals · Condition: Huntington Disease

- Company: Novartis Pharmaceuticals
- Sector: neurology
- Primary source: https://clinicaltrials.gov/study/NCT07326709

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.